Company / SG&A per Share
Processa Pharmaceuticals, Inc. SG&A per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.30
FY2022
5-year range
$0.09 / $0.35
FY2018-FY2022
Trend
+29.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.09 to $0.30 over the past 6 years.
Based on SEC 10-K filings.
0.30 in FY2022.
Increased from $0.09 to $0.30 over the past 6 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, sg&a per share increased 29.7% year-over-year.
- Peak sg&a per share was recorded in FY2013.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.30 | +29.7% |
| FY2021 | $0.23 | +168.2% |
| FY2016 | $0.09 | -53.5% |
| FY2015 | $0.18 | -47.1% |
| FY2014 | $0.35 | -65.9% |
| FY2013 | $1.02 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026